Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IUHE.AS(EUR) CXE
ETF Ticker IUHE(EUR) Euronext Amsterdam

Holdings detail for INCY

Stock Name	Incyte Corporation
Ticker	INCY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45337C1027
LEI	549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib: (RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update: Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY): Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00: Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY): Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC: Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY): Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.: Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY): Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC: Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY): Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY): State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY): Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY): Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY): Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus: Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares S&P 500 Health Care Sector UCITS ETF INCY holdings

Date	Number of INCY Shares Held	Base Market Value of INCY Shares	Local Market Value of INCY Shares	Change in INCY Shares Held	Change in INCY Base Value	Current Price per INCY Share Held	Previous Price per INCY Share Held
2025-12-03 (Wednesday)	81,820	USD 8,304,730	USD 8,304,730	0	USD 4,909	USD 101.5	USD 101.44
2025-12-02 (Tuesday)	81,820	USD 8,299,821	USD 8,299,821	-1,012	USD -152,356	USD 101.44	USD 102.04
2025-12-01 (Monday)	82,832	USD 8,452,177	USD 8,452,177	30	USD -197,320	USD 102.04	USD 104.46
2025-11-28 (Friday)	82,802	USD 8,649,497	USD 8,649,497	546	USD -40,849	USD 104.46	USD 105.65
2025-11-27 (Thursday)	82,256	USD 8,690,346	USD 8,690,346	0	USD 0	USD 105.65	USD 105.65
2025-11-26 (Wednesday)	82,256	USD 8,690,346	USD 8,690,346	-184	USD -11,196	USD 105.65	USD 105.55
2025-11-25 (Tuesday)	82,440	USD 8,701,542	USD 8,701,542	184	USD -37,335	USD 105.55	USD 106.24
2025-11-24 (Monday)	82,256	USD 8,738,877	USD 8,738,877	455	USD 390,267	USD 106.24	USD 102.06
2025-11-21 (Friday)	81,801	USD 8,348,610	USD 8,348,610	0	USD 24,540	USD 102.06	USD 101.76
2025-11-20 (Thursday)	81,801	USD 8,324,070	USD 8,324,070	91	USD 45,213	USD 101.76	USD 101.32
2025-11-19 (Wednesday)	81,710	USD 8,278,857	USD 8,278,857	0	USD -209,995	USD 101.32	USD 103.89
2025-11-18 (Tuesday)	81,710	USD 8,488,852	USD 8,488,852	0	USD -22,879	USD 103.89	USD 104.17
2025-11-17 (Monday)	81,710	USD 8,511,731	USD 8,511,731	0	USD 1,634	USD 104.17	USD 104.15

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BMBKBZ46

Show aggregate share trades of INCY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 SELL -1,012 103.540 100.550 100.849 USD -102,059 74.47 Loss of -26,700 on sale
2025-12-01 BUY 30 103.890 101.470 101.712 USD 3,051 74.34
2025-11-28 BUY 546 106.990 103.850 104.164 USD 56,874 74.21
2025-11-26 SELL -184 107.000 105.085 105.276 USD -19,371 73.92 Loss of -5,769 on sale
2025-11-26 SELL -184 107.000 105.085 105.276 USD -19,371 73.92 Loss of -5,769 on sale
2025-11-25 BUY 184 107.605 105.160 105.405 USD 19,394 73.78
2025-11-24 BUY 455 106.670 102.503 102.920 USD 46,828 73.63
2025-11-20 BUY 91 103.225 101.080 101.295 USD 9,218 73.37
2025-11-12 SELL -364 109.275 106.810 107.056 USD -38,969 72.49 Loss of -12,581 on sale
2025-11-10 BUY 910 108.810 104.070 104.544 USD 95,135 72.16
2025-11-06 BUY 91 106.430 103.075 103.410 USD 9,410 71.84
2025-11-05 SELL -91 106.470 101.500 101.997 USD -9,282 71.68 Loss of -2,759 on sale
2025-11-04 BUY 91 103.860 100.020 100.404 USD 9,137 71.53
2025-10-31 BUY 460 95.100 92.058 92.362 USD 42,486 71.27
2025-10-30 SELL -552 94.620 91.190 91.533 USD -50,526 71.17 Loss of -11,242 on sale
2025-10-29 SELL -184 90.180 94.420 93.996 USD -17,295 71.07 Loss of -4,218 on sale
2025-10-28 BUY 175 91.650 93.980 93.747 USD 16,406 70.97
2025-10-27 SELL -184 93.080 93.170 93.161 USD -17,142 70.86 Loss of -4,103 on sale
2025-10-22 SELL -92 88.060 88.210 88.195 USD -8,114 70.58 Loss of -1,621 on sale
2025-10-17 SELL -368 87.570 88.540 88.443 USD -32,547 70.32 Loss of -6,669 on sale
2025-10-16 BUY 460 87.310 92.860 92.305 USD 42,460 70.23
2025-10-15 BUY 644 88.150 88.490 88.456 USD 56,966 70.14
2025-10-14 BUY 92 85.960 86.160 86.140 USD 7,925 70.06
2025-10-03 BUY 182 86.850 86.980 86.967 USD 15,828 69.97
2025-10-02 BUY 91 86.280 88.660 88.422 USD 8,046 69.88
2025-10-01 BUY 530 86.700 87.240 87.186 USD 46,209 69.79
2025-09-24 BUY 2,238 84.160 84.820 84.754 USD 189,679 69.42
2025-09-18 BUY 89 86.000 86.070 86.063 USD 7,660 69.33
2025-09-12 BUY 235 83.100 85.510 85.269 USD 20,038 69.01
2025-09-11 BUY 89 86.170 87.100 87.007 USD 7,744 68.91
2025-09-10 BUY 89 86.250 86.940 86.871 USD 7,732 68.81
2025-08-20 BUY 176 86.200 86.370 86.353 USD 15,198 68.51
2025-08-19 BUY 88 85.460 85.690 85.667 USD 7,539 68.41
2025-08-18 BUY 440 84.920 87.240 87.008 USD 38,284 68.31
2025-08-15 BUY 1,326 86.920 87.060 87.046 USD 115,423 68.21
2025-08-14 BUY 534 86.160 86.500 86.466 USD 46,173 68.10
2025-08-13 BUY 356 85.850 86.020 86.003 USD 30,617 67.99
2025-07-30 BUY 89 77.550 78.770 78.648 USD 7,000 67.85
2025-07-17 SELL -89 68.940 69.650 69.579 USD -6,193 67.72 Loss of -166 on sale
2025-07-15 SELL -356 68.250 70.150 69.960 USD -24,906 67.70 Loss of -803 on sale
2025-07-14 SELL -890 69.980 70.040 70.034 USD -62,330 67.69 Loss of -2,086 on sale
2025-07-09 SELL -89 68.720 69.300 69.242 USD -6,163 67.66 Loss of -141 on sale
2025-07-07 SELL -178 67.270 68.250 68.152 USD -12,131 67.66 Loss of -87 on sale
2025-07-02 BUY 89 68.170 69.100 69.007 USD 6,142 67.65
2025-06-24 SELL -1,513 69.010 69.540 69.487 USD -105,134 67.61 Loss of -2,843 on sale
2025-06-23 BUY 89 67.260 68.780 68.628 USD 6,108 67.61
2025-06-20 SELL -178 68.460 69.190 69.117 USD -12,303 67.60 Loss of -269 on sale
2025-06-18 SELL -89 68.270 69.470 69.350 USD -6,172 67.59 Loss of -156 on sale
2025-06-17 BUY 1,068 68.810 70.890 70.682 USD 75,488 67.59
2025-06-13 SELL -178 67.750 68.960 68.839 USD -12,253 67.56 Loss of -228 on sale
2025-06-11 SELL -89 68.850 70.360 70.209 USD -6,249 67.54 Loss of -238 on sale
2025-06-10 SELL -178 70.070 70.980 70.889 USD -12,618 67.52 Loss of -600 on sale
2025-06-09 SELL -267 69.890 69.960 69.953 USD -18,677 67.50 Loss of -656 on sale
2025-05-21 SELL -89 64.780 65.460 65.392 USD -5,820 67.69 Profit of 204 on sale
2025-05-20 SELL -178 65.300 66.110 66.029 USD -11,753 67.71 Profit of 299 on sale
2025-05-15 SELL -267 62.760 62.990 62.967 USD -16,812 67.83 Profit of 1,298 on sale
2025-05-14 SELL -267 61.160 62.500 62.366 USD -16,652 67.89 Profit of 1,474 on sale
2025-05-13 BUY 89 60.810 61.150 61.116 USD 5,439 67.95
2025-05-09 SELL -89 58.980 60.480 60.330 USD -5,369 68.10 Profit of 691 on sale
2025-05-08 BUY 178 59.730 59.990 59.964 USD 10,674 68.18
2025-05-01 BUY 178 62.030 62.640 62.579 USD 11,139 68.52
2025-04-24 SELL -89 58.970 59.050 59.042 USD -5,255 68.94 Profit of 881 on sale
2025-04-23 BUY 267 58.000 59.010 58.909 USD 15,729 69.06
2025-04-15 SELL -89 58.460 59.950 59.801 USD -5,322 69.80 Profit of 890 on sale
2025-04-10 SELL -174 55.170 58.330 58.014 USD -10,094 70.23 Profit of 2,126 on sale
2025-04-08 SELL -87 56.970 61.470 61.020 USD -5,309 70.52 Profit of 826 on sale
2025-04-07 SELL -87 60.290 61.060 60.983 USD -5,306 70.64 Profit of 840 on sale
2025-04-04 SELL -174 60.580 63.570 63.271 USD -11,009 70.76 Profit of 1,303 on sale
2025-04-02 BUY 87 62.330 62.530 62.510 USD 5,438 70.86
2025-04-01 BUY 783 60.910 62.000 61.891 USD 48,461 70.98
2025-03-31 SELL -522 60.550 60.810 60.784 USD -31,729 71.11 Profit of 5,390 on sale
2025-03-28 BUY 87 60.600 60.970 60.933 USD 5,301 71.24
2025-03-26 SELL -57 61.260 62.880 62.718 USD -3,575 71.50 Profit of 501 on sale
2025-03-21 BUY 609 61.920 62.330 62.289 USD 37,934 71.87
2025-03-20 BUY 356 60.580 61.750 61.633 USD 21,941 72.03
2025-03-17 SELL -88 62.010 63.450 63.306 USD -5,571 72.50 Profit of 809 on sale
2025-03-12 BUY 2,435 67.730 68.230 68.180 USD 166,018 72.71
2025-03-07 BUY 86 70.790 72.810 72.608 USD 6,244 72.84
2025-02-28 SELL -258 73.500 73.630 73.617 USD -18,993 72.97 Loss of -167 on sale
2025-02-25 BUY 860 74.400 76.240 76.056 USD 65,408 72.92
2025-02-20 BUY 602 71.380 71.520 71.506 USD 43,047 72.94
2025-02-19 BUY 258 70.160 71.430 71.303 USD 18,396 72.99
2025-02-18 BUY 172 71.270 71.680 71.639 USD 12,322 73.02
2025-02-13 BUY 430 70.010 72.690 72.422 USD 31,141 73.19
2025-02-04 BUY 344 74.120 74.920 74.840 USD 25,745 73.42
2025-01-31 BUY 86 74.160 75.180 75.078 USD 6,457 73.40
2025-01-29 BUY 86 73.720 74.110 74.071 USD 6,370 73.38
2025-01-27 BUY 172 72.640 73.430 73.351 USD 12,616 73.41
2025-01-24 BUY 86 72.590 73.680 73.571 USD 6,327 73.43
2025-01-02 SELL -3,093 69.530 70.270 70.196 USD -217,116 73.57 Profit of 10,441 on sale
2024-12-10 SELL -85 72.480 73.100 73.038 USD -6,208 73.60 Profit of 48 on sale
2024-12-09 SELL -2,210 72.110 75.980 75.593 USD -167,061 73.65 Loss of -4,291 on sale
2024-12-03 SELL -1,020 72.030 72.960 72.867 USD -74,324 73.55 Profit of 695 on sale
2024-12-02 SELL -425 73.240 74.700 74.554 USD -31,685 73.56 Loss of -422 on sale
2024-11-29 SELL -86 74.590 76.080 75.931 USD -6,530 73.52 Loss of -207 on sale
2024-11-22 SELL -850 71.720 72.000 71.972 USD -61,176 73.36 Profit of 1,181 on sale
2024-11-21 SELL -425 70.390 71.400 71.299 USD -30,302 73.51 Profit of 940 on sale
2024-11-20 BUY 680 71.050 71.680 71.617 USD 48,700 73.64
2024-11-18 SELL -1,020 76.970 77.010 77.006 USD -78,546 73.62 Loss of -3,449 on sale
2024-11-11 BUY 765 81.530 83.540 83.339 USD 63,754 72.63
2024-11-08 SELL -2,720 83.380 83.950 83.893 USD -228,189 71.87 Loss of -32,712 on sale
2024-11-07 SELL -168 82.340 82.970 82.907 USD -13,928 71.06 Loss of -1,990 on sale
2024-11-01 SELL -168 76.130 76.330 76.310 USD -12,820 68.19 Loss of -1,365 on sale
2024-10-31 SELL -344 74.120 74.680 74.624 USD -25,671 67.44 Loss of -2,470 on sale
2024-10-30 BUY 85 73.930 74.600 74.533 USD 6,335 66.52
2024-10-29 BUY 516 73.600 74.070 74.023 USD 38,196 65.34
2024-10-28 SELL -258 65.690 65.880 65.861 USD -16,992 65.27 Loss of -153 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	SELL	-1,012	103.540	100.550	100.849	USD -102,059	74.47 Loss of -26,700 on sale
2025-12-01	BUY	30	103.890	101.470	101.712	USD 3,051	74.34
2025-11-28	BUY	546	106.990	103.850	104.164	USD 56,874	74.21
2025-11-26	SELL	-184	107.000	105.085	105.276	USD -19,371	73.92 Loss of -5,769 on sale
2025-11-26	SELL	-184	107.000	105.085	105.276	USD -19,371	73.92 Loss of -5,769 on sale
2025-11-25	BUY	184	107.605	105.160	105.405	USD 19,394	73.78
2025-11-24	BUY	455	106.670	102.503	102.920	USD 46,828	73.63
2025-11-20	BUY	91	103.225	101.080	101.295	USD 9,218	73.37
2025-11-12	SELL	-364	109.275	106.810	107.056	USD -38,969	72.49 Loss of -12,581 on sale
2025-11-10	BUY	910	108.810	104.070	104.544	USD 95,135	72.16
2025-11-06	BUY	91	106.430	103.075	103.410	USD 9,410	71.84
2025-11-05	SELL	-91	106.470	101.500	101.997	USD -9,282	71.68 Loss of -2,759 on sale
2025-11-04	BUY	91	103.860	100.020	100.404	USD 9,137	71.53
2025-10-31	BUY	460	95.100	92.058	92.362	USD 42,486	71.27
2025-10-30	SELL	-552	94.620	91.190	91.533	USD -50,526	71.17 Loss of -11,242 on sale
2025-10-29	SELL	-184	90.180	94.420	93.996	USD -17,295	71.07 Loss of -4,218 on sale
2025-10-28	BUY	175	91.650	93.980	93.747	USD 16,406	70.97
2025-10-27	SELL	-184	93.080	93.170	93.161	USD -17,142	70.86 Loss of -4,103 on sale
2025-10-22	SELL	-92	88.060	88.210	88.195	USD -8,114	70.58 Loss of -1,621 on sale
2025-10-17	SELL	-368	87.570	88.540	88.443	USD -32,547	70.32 Loss of -6,669 on sale
2025-10-16	BUY	460	87.310	92.860	92.305	USD 42,460	70.23
2025-10-15	BUY	644	88.150	88.490	88.456	USD 56,966	70.14
2025-10-14	BUY	92	85.960	86.160	86.140	USD 7,925	70.06
2025-10-03	BUY	182	86.850	86.980	86.967	USD 15,828	69.97
2025-10-02	BUY	91	86.280	88.660	88.422	USD 8,046	69.88
2025-10-01	BUY	530	86.700	87.240	87.186	USD 46,209	69.79
2025-09-24	BUY	2,238	84.160	84.820	84.754	USD 189,679	69.42
2025-09-18	BUY	89	86.000	86.070	86.063	USD 7,660	69.33
2025-09-12	BUY	235	83.100	85.510	85.269	USD 20,038	69.01
2025-09-11	BUY	89	86.170	87.100	87.007	USD 7,744	68.91
2025-09-10	BUY	89	86.250	86.940	86.871	USD 7,732	68.81
2025-08-20	BUY	176	86.200	86.370	86.353	USD 15,198	68.51
2025-08-19	BUY	88	85.460	85.690	85.667	USD 7,539	68.41
2025-08-18	BUY	440	84.920	87.240	87.008	USD 38,284	68.31
2025-08-15	BUY	1,326	86.920	87.060	87.046	USD 115,423	68.21
2025-08-14	BUY	534	86.160	86.500	86.466	USD 46,173	68.10
2025-08-13	BUY	356	85.850	86.020	86.003	USD 30,617	67.99
2025-07-30	BUY	89	77.550	78.770	78.648	USD 7,000	67.85
2025-07-17	SELL	-89	68.940	69.650	69.579	USD -6,193	67.72 Loss of -166 on sale
2025-07-15	SELL	-356	68.250	70.150	69.960	USD -24,906	67.70 Loss of -803 on sale
2025-07-14	SELL	-890	69.980	70.040	70.034	USD -62,330	67.69 Loss of -2,086 on sale
2025-07-09	SELL	-89	68.720	69.300	69.242	USD -6,163	67.66 Loss of -141 on sale
2025-07-07	SELL	-178	67.270	68.250	68.152	USD -12,131	67.66 Loss of -87 on sale
2025-07-02	BUY	89	68.170	69.100	69.007	USD 6,142	67.65
2025-06-24	SELL	-1,513	69.010	69.540	69.487	USD -105,134	67.61 Loss of -2,843 on sale
2025-06-23	BUY	89	67.260	68.780	68.628	USD 6,108	67.61
2025-06-20	SELL	-178	68.460	69.190	69.117	USD -12,303	67.60 Loss of -269 on sale
2025-06-18	SELL	-89	68.270	69.470	69.350	USD -6,172	67.59 Loss of -156 on sale
2025-06-17	BUY	1,068	68.810	70.890	70.682	USD 75,488	67.59
2025-06-13	SELL	-178	67.750	68.960	68.839	USD -12,253	67.56 Loss of -228 on sale
2025-06-11	SELL	-89	68.850	70.360	70.209	USD -6,249	67.54 Loss of -238 on sale
2025-06-10	SELL	-178	70.070	70.980	70.889	USD -12,618	67.52 Loss of -600 on sale
2025-06-09	SELL	-267	69.890	69.960	69.953	USD -18,677	67.50 Loss of -656 on sale
2025-05-21	SELL	-89	64.780	65.460	65.392	USD -5,820	67.69 Profit of 204 on sale
2025-05-20	SELL	-178	65.300	66.110	66.029	USD -11,753	67.71 Profit of 299 on sale
2025-05-15	SELL	-267	62.760	62.990	62.967	USD -16,812	67.83 Profit of 1,298 on sale
2025-05-14	SELL	-267	61.160	62.500	62.366	USD -16,652	67.89 Profit of 1,474 on sale
2025-05-13	BUY	89	60.810	61.150	61.116	USD 5,439	67.95
2025-05-09	SELL	-89	58.980	60.480	60.330	USD -5,369	68.10 Profit of 691 on sale
2025-05-08	BUY	178	59.730	59.990	59.964	USD 10,674	68.18
2025-05-01	BUY	178	62.030	62.640	62.579	USD 11,139	68.52
2025-04-24	SELL	-89	58.970	59.050	59.042	USD -5,255	68.94 Profit of 881 on sale
2025-04-23	BUY	267	58.000	59.010	58.909	USD 15,729	69.06
2025-04-15	SELL	-89	58.460	59.950	59.801	USD -5,322	69.80 Profit of 890 on sale
2025-04-10	SELL	-174	55.170	58.330	58.014	USD -10,094	70.23 Profit of 2,126 on sale
2025-04-08	SELL	-87	56.970	61.470	61.020	USD -5,309	70.52 Profit of 826 on sale
2025-04-07	SELL	-87	60.290	61.060	60.983	USD -5,306	70.64 Profit of 840 on sale
2025-04-04	SELL	-174	60.580	63.570	63.271	USD -11,009	70.76 Profit of 1,303 on sale
2025-04-02	BUY	87	62.330	62.530	62.510	USD 5,438	70.86
2025-04-01	BUY	783	60.910	62.000	61.891	USD 48,461	70.98
2025-03-31	SELL	-522	60.550	60.810	60.784	USD -31,729	71.11 Profit of 5,390 on sale
2025-03-28	BUY	87	60.600	60.970	60.933	USD 5,301	71.24
2025-03-26	SELL	-57	61.260	62.880	62.718	USD -3,575	71.50 Profit of 501 on sale
2025-03-21	BUY	609	61.920	62.330	62.289	USD 37,934	71.87
2025-03-20	BUY	356	60.580	61.750	61.633	USD 21,941	72.03
2025-03-17	SELL	-88	62.010	63.450	63.306	USD -5,571	72.50 Profit of 809 on sale
2025-03-12	BUY	2,435	67.730	68.230	68.180	USD 166,018	72.71
2025-03-07	BUY	86	70.790	72.810	72.608	USD 6,244	72.84
2025-02-28	SELL	-258	73.500	73.630	73.617	USD -18,993	72.97 Loss of -167 on sale
2025-02-25	BUY	860	74.400	76.240	76.056	USD 65,408	72.92
2025-02-20	BUY	602	71.380	71.520	71.506	USD 43,047	72.94
2025-02-19	BUY	258	70.160	71.430	71.303	USD 18,396	72.99
2025-02-18	BUY	172	71.270	71.680	71.639	USD 12,322	73.02
2025-02-13	BUY	430	70.010	72.690	72.422	USD 31,141	73.19
2025-02-04	BUY	344	74.120	74.920	74.840	USD 25,745	73.42
2025-01-31	BUY	86	74.160	75.180	75.078	USD 6,457	73.40
2025-01-29	BUY	86	73.720	74.110	74.071	USD 6,370	73.38
2025-01-27	BUY	172	72.640	73.430	73.351	USD 12,616	73.41
2025-01-24	BUY	86	72.590	73.680	73.571	USD 6,327	73.43
2025-01-02	SELL	-3,093	69.530	70.270	70.196	USD -217,116	73.57 Profit of 10,441 on sale
2024-12-10	SELL	-85	72.480	73.100	73.038	USD -6,208	73.60 Profit of 48 on sale
2024-12-09	SELL	-2,210	72.110	75.980	75.593	USD -167,061	73.65 Loss of -4,291 on sale
2024-12-03	SELL	-1,020	72.030	72.960	72.867	USD -74,324	73.55 Profit of 695 on sale
2024-12-02	SELL	-425	73.240	74.700	74.554	USD -31,685	73.56 Loss of -422 on sale
2024-11-29	SELL	-86	74.590	76.080	75.931	USD -6,530	73.52 Loss of -207 on sale
2024-11-22	SELL	-850	71.720	72.000	71.972	USD -61,176	73.36 Profit of 1,181 on sale
2024-11-21	SELL	-425	70.390	71.400	71.299	USD -30,302	73.51 Profit of 940 on sale
2024-11-20	BUY	680	71.050	71.680	71.617	USD 48,700	73.64
2024-11-18	SELL	-1,020	76.970	77.010	77.006	USD -78,546	73.62 Loss of -3,449 on sale
2024-11-11	BUY	765	81.530	83.540	83.339	USD 63,754	72.63
2024-11-08	SELL	-2,720	83.380	83.950	83.893	USD -228,189	71.87 Loss of -32,712 on sale
2024-11-07	SELL	-168	82.340	82.970	82.907	USD -13,928	71.06 Loss of -1,990 on sale
2024-11-01	SELL	-168	76.130	76.330	76.310	USD -12,820	68.19 Loss of -1,365 on sale
2024-10-31	SELL	-344	74.120	74.680	74.624	USD -25,671	67.44 Loss of -2,470 on sale
2024-10-30	BUY	85	73.930	74.600	74.533	USD 6,335	66.52
2024-10-29	BUY	516	73.600	74.070	74.023	USD 38,196	65.34
2024-10-28	SELL	-258	65.690	65.880	65.861	USD -16,992	65.27 Loss of -153 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	321,923	395	451,110	71.4%
2025-09-18	244,947	1,423	469,747	52.1%
2025-09-17	277,858	779	546,953	50.8%
2025-09-16	359,781	946	576,379	62.4%
2025-09-15	347,453	4	582,228	59.7%
2025-09-12	353,040	0	631,534	55.9%
2025-09-11	448,733	3,894	739,701	60.7%
2025-09-10	490,727	248	671,932	73.0%
2025-09-09	515,395	1,822	682,791	75.5%
2025-09-08	308,184	119	479,828	64.2%
2025-09-05	256,719	2,505	512,049	50.1%
2025-09-04	422,624	1,507	834,717	50.6%
2025-09-03	381,679	7,777	624,922	61.1%
2025-09-02	547,120	15,396	816,267	67.0%
2025-08-29	148,294	262	304,427	48.7%
2025-08-28	164,008	0	347,480	47.2%
2025-08-27	248,926	453	513,401	48.5%
2025-08-26	365,130	6	709,320	51.5%
2025-08-25	478,130	1,306	642,319	74.4%
2025-08-22	344,352	2,023	596,301	57.7%
2025-08-21	198,729	4,881	335,301	59.3%
2025-08-20	351,699	3,977	555,345	63.3%
2025-08-19	343,110	3,146	574,328	59.7%
2025-08-18	366,124	4,996	653,103	56.1%
2025-08-15	480,885	8,035	625,797	76.8%
2025-08-14	593,554	36,654	806,068	73.6%
2025-08-13	845,181	98,160	1,257,503	67.2%
2025-08-12	462,896	42,208	678,689	68.2%
2025-08-11	385,211	696	595,892	64.6%
2025-08-08	248,925	738	426,187	58.4%
2025-08-07	268,864	929	420,486	63.9%
2025-08-06	554,642	891	731,484	75.8%
2025-08-05	361,687	2,092	623,879	58.0%
2025-08-04	338,005	1,464	519,150	65.1%
2025-08-01	414,814	828	572,879	72.4%
2025-07-31	570,845	6,148	777,417	73.4%
2025-07-30	471,303	14,166	881,194	53.5%
2025-07-29	966,640	10,581	1,593,701	60.7%
2025-07-28	382,236	62	625,510	61.1%
2025-07-25	216,967	49	422,990	51.3%
2025-07-24	348,276	23	528,517	65.9%
2025-07-23	297,903	583	487,297	61.1%
2025-07-22	267,987	172	446,489	60.0%
2025-07-21	223,626	380	406,729	55.0%
2025-07-18	241,218	108	471,589	51.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.